Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway

By L. Arbibe, J. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P. Godowski, R. Ulevitch, U. Knaus. Nature Immunology, 2000

681 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology

View Paper: https://www.semanticscholar.org/paper/525281f9be69c68eb11e367e31c7f82539735c6c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Shizuo Akira
2. K. Takeda
3. T. Kaisho
4. Johannes A. Schmid
5. Bastian Hoesel
6. R. Medzhitov
7. Taro Kawai
8. B. Beutler

In Immunology

1. Shizuo Akira
2. K. Takeda
3. T. Kaisho
4. R. Medzhitov
5. Johannes A. Schmid
6. Bastian Hoesel
7. Taro Kawai
8. O. Takeuchi

Citations in the corpus

• The complexity of NF-κB signaling in inflammation and cancer (2013, background): “This has been reported for instance for the influence of Akt on NF-κB, which is activating in cell types such as epithelial cells, but can be inhibitory in macrophages [137-140].”